Application of C-JNK (JUN N terminal kinase) inhibitor SU3327
A C-JUNN, 1.C-JUNN technology, used in antifungal agents, resistance to vector-borne diseases, medical preparations containing active ingredients, etc., can solve problems such as affecting transcription
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0014] Based on the deep learning technology, the present invention automatically finds potential new antibiotics from the existing or safe drug database in the clinical trial stage. The susceptibility test of bacteria confirmed that SU3327 has broad-spectrum antibiotic activity. The invention provides a novel antibiotic, which further brings important influence to the field of medicine.
[0015] Bacterial susceptibility tests were used to determine the susceptibility of SU3327 to Escherichia coli ATCC25922, Staphylococcus aureus CMCC (B) 26003, Staphylococcus aureus MRSA ATCC43300, Acinetobacter baumannii ATCC19606, Clostridium sporogenes CMCC (B) 64941, Bacillus subtilis CMCC (B) Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 63501, Candida albicans ATCC10231. It can be seen from the experimental results that SU3327 has good antibacterial ability and can be used as a broad-spectrum antibiotic to effectively reduce the mortality rate o...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com